Donna Fu, PhD, DABT

Senior Program Manager @ WuXi AppTec

Country

United States

City

Greater Seattle Area

Industry

Pharmaceuticals

Skill

Formulation development, Biomarker Development, Liquid Chromatography-Mass Spectrometry (LC-MS), Drug Development, Drug Discovery, Toxicology, Pharmacology, DMPK, Bioanalysis, Program Management

Experience

Senior Program Manager

WuXi AppTec

2021 - Present · 5 yrs

Lead and manage the integrated IND-enabling and post-IND programs of various drug modalities and disease indications for global regulatory submission. Provide scientific/technical support for IND-enabling and post-IND business development.

Associate Professional Researcher

University of California, San Francisco

2018 - 2021 · 3 yrs

Lead and manage a portfolio of DMPK, biomarker, and toxicology studies in drug discovery programs for neurodegenerative diseases in a cross-functional team with chemists, pharmacologists, biologists, toxicologists, and pathologists, and in collaboration with pharmaceutical companies. Point of contact for the ADMET outsourcing service, with proven record of guiding study design, trouble-shooting assays, and critical report review with CROs.

Senior Fellow

University of Washington

2015 - 2018 · 3 yrs

Investigate the regulation of drug metabolism, microbiome, and bile acid homeostasis by environmental toxicants (PCBs, PBDEs).

Assistant Professor

Harbin Medical University

2013 - 2015 · 2 yrs

Investigate the role of microRNAs in aging-related neurodegenerative and cardiovascular diseases.

Education

University of Kansas Medical Center

Toxicology

Regulation of drug metabolism and bile acid homeostasis during aging and by anti-aging intervention calorie restriction. Effect of antihypertensive drugs on bile acid homeostasis.